- Open Access
Haploinsufficiency of autism causative gene Tbr1 impairs olfactory discrimination and neuronal activation of the olfactory system in mice
Molecular Autism volume 10, Article number: 5 (2019)
Autism spectrum disorders (ASD) exhibit two clusters of core symptoms, i.e., social and communication impairment, and repetitive behaviors and sensory abnormalities. Our previous study demonstrated that TBR1, a causative gene of ASD, controls axonal projection and neuronal activation of amygdala and regulates social interaction and vocal communication in a mouse model. Behavioral defects caused by Tbr1 haploinsufficiency can be ameliorated by increasing neural activity via D-cycloserine treatment, an N-methyl-D-aspartate receptor (NMDAR) coagonist. In this report, we investigate the role of TBR1 in regulating olfaction and test whether D-cycloserine can also improve olfactory defects in Tbr1 mutant mice.
We used Tbr1+/− mice as a model to investigate the function of TBR1 in olfactory sensation and discrimination of non-social odors. We employed a behavioral assay to characterize the olfactory defects of Tbr1+/− mice. Magnetic resonance imaging (MRI) and histological analysis were applied to characterize anatomical features. Immunostaining was performed to further analyze differences in expression of TBR1 subfamily members (namely TBR1, TBR2, and TBX21), interneuron populations, and dendritic abnormalities in olfactory bulbs. Finally, C-FOS staining was used to monitor neuronal activation of the olfactory system upon odor stimulation.
Tbr1+/− mice exhibited smaller olfactory bulbs and anterior commissures, reduced interneuron populations, and an abnormal dendritic morphology of mitral cells in the olfactory bulbs. Tbr1 haploinsufficiency specifically impaired olfactory discrimination but not olfactory sensation. Neuronal activation upon odorant stimulation was reduced in the glomerular layer of Tbr1+/− olfactory bulbs. Furthermore, although the sizes of piriform and perirhinal cortices were not affected by Tbr1 deficiency, neuronal activation was reduced in these two cortical regions in response to odorant stimulation. These results suggest an impairment of neuronal activation in olfactory bulbs and defective connectivity from olfactory bulbs to the upper olfactory system in Tbr1+/− mice. Systemic administration of D-cycloserine, an NMDAR co-agonist, ameliorated olfactory discrimination in Tbr1+/− mice, suggesting that increased neuronal activity has a beneficial effect on Tbr1 deficiency.
Tbr1 regulates neural circuits and activity in the olfactory system to control olfaction. Tbr1+/− mice can serve as a suitable model for revealing how an autism causative gene controls neuronal circuits, neural activity, and autism-related behaviors.
Autism spectrum disorders (ASDs) are highly prevalent neurodevelopmental disorders [1, 2]. Patients with ASD feature two core behavioral symptoms, termed the ASD dyad; one is social and communication impairment, and the other is repetitive behaviors and sensory abnormalities [3, 4]. Many molecular etiological studies using animal models have been conducted to investigate social interaction, vocal communication, and repetitive behaviors [5,6,7,8]. Regarding sensory dysregulation, mouse models with Mecp2 and Fmr1 deficiencies have been used to study defects in tactile, visual, auditory, and olfactory responses [9,10,11,12,13,14,15,16,17,18,19]. However, there have been fewer investigations of sensory dysregulation in other ASD animal models exhibiting deficiencies in other ASD causative genes. It is also unclear if mouse models can reflect the diverse variations of sensory dysfunction in patients with ASD.
Based on human genetic studies using whole-exome sequencing analyses, the brain-specific T-box transcription factor gene T-brain-1 (TBR1) is a causative gene of ASD [20,21,22]. De novo loss-of-function and missense mutations in one allele of TBR1 are recurrently identified in patients with ASD [20,21,22]. Echoing the mutations identified in patients, Tbr1+/− mice exhibit autism-like behaviors, including reduced social interaction, impaired learning and memory, and aberrant cognitive flexibility .
Tbr1 is critical for both forebrain development and neuronal activation. Deletion of Tbr1 impairs neuronal migration of the cerebral cortex and amygdalae [24, 25], axonal projection of the cerebral cortex and amygdalae [23, 24], and differentiation of projection neurons in the olfactory bulb , resulting in neonatal lethality within 1–2 days of birth . When only one of the two Tbr1 alleles is deleted in mutant mouse models—representing a scenario imitating the genotype of ASD patients [20,21,22]—the gross anatomy and structure of the Tbr1+/− mutant mouse brains do not exhibit obvious defects , but the posterior part of their anterior commissure (the white matter structure connecting the two amygdalae of the two brain hemispheres) is much smaller or even missing . For amygdalar neurons, Tbr1 heterozygosity influences the expression of a set of genes, including Ntng1, Cntn2, and Cdh8 [23, 27], that impairs axonal extension and differentiation, thereby resulting in reduced inter- and intra-amygdalar axonal connections . In addition to controlling axonal projection, Tbr1 is also required for neuronal activation. It acts as an immediate early gene to bind the promoter of Grin2b [28, 29] and regulate Grin2b expression in response to neuronal activation . Since Grin2b encodes a critical subunit of N-methyl-D-aspartate receptor (NMDAR), an important glutamate receptor involved in learning/memory and a variety of neurological disorders including autism and schizophrenia [20, 31], TBR1 regulates neuronal activity and functions by controlling Grin2b expression. Thus, TBR1 plays dual roles in neurons, namely regulation of axonal projection and control of neuronal activation. The axonal projection controlled by TBR1 necessitates correct neural circuit formation. The cell-autonomous effect of TBR1 on the control of Grin2b expression thereby synergizes with TBR1-mediated regulation of axonal projection to control the activity of specific neural circuits. This scenario is supported by the observation that local infusion of D-cycloserine, an NMDAR coagonist, into amygdalae ameliorates the autism-like behaviors exhibited by Tbr1+/− mice . Although the developmental defects (axonal projection) cannot be rescued, increased neuronal activity at the adult stage is sufficient to ameliorate the behavioral defects caused by Tbr1 haploinsufficiency.
Studies of Tbr1−/− mice have shown that, apart from the cortex and amygdalae, Tbr1 is also critical for the development of projection neurons in the olfactory bulb [26, 32, 33]. It would be intriguing to explore whether Tbr1+/− mice also exhibit impaired olfaction because olfactory dysfunction has been reported in patients with ASD [34,35,36,37,38,39,40,41,42]. Several mouse studies have revealed the influence of olfactory responses in social interaction and ultrasonic vocalization [43,44,45]. However, abnormal olfactory responses in ASD patients are not necessarily related to social interaction. Children with ASD tend to exhibit strong food selectivity, which is at least partially due to abnormal olfactory responses [38, 46]. Olfactory responses to non-social odors remain rather unexplored in mouse models harboring ASD-linked mutations.
Depending on cohorts and experimental design, the ASD-linked impairments in olfactory responses to non-social odors are quite diverse [47, 48]. Hypo- or hyper-olfactory sensitivity and impaired odor identification are frequently observed in ASD patients [34,35,36,37,38,39,40,41,42]. Previous studies have indicated that patients with ASD exhibit normal food odor-sensing ability but have a lower discrimination score [34, 35, 39]. We were interested in investigating whether Tbr1 haploinsufficiency results in abnormal olfactory processing in response to non-social odors. Using Tbr1+/− mice, we found that olfactory discrimination is sensitive to Tbr1 deficiency. This outcome is probably due to altered cell identity (including changes in the property of projection neurons and the number of interneurons) and abnormal neuronal circuits in the olfactory system, which consequently reduces neuronal activation in the olfactory system including in the glomerular layer of olfactory bulbs and piriform and perirhinal cortices of Tbr1+/− mice. As found for other autism-like behaviors, systemic administration of D-cycloserine fully ameliorated the defect of olfactory discrimination we observed in Tbr1+/− mice. Our data suggest that Tbr1 haploinsufficiency alters neuronal circuits in the olfactory system and impairs olfactory discrimination of non-social odors, one of the core symptoms of ASD.
Tbr1+/− mice were used to evaluate the role of Tbr1 in olfaction. Olfactory sensation and discrimination of Tbr1+/− mice were first investigated by behavioral assay. Histological analysis, magnetic resonance imaging (MRI), and immunostaining were then used to characterize the etiology of Tbr1 deficiency in terms of olfactory responses.
The Tbr1+/− mice  were originally provided by Drs. R. F. Hevner (Department of Neurological Surgery, University of Washington, Seattle) and J. L. Rubenstein (Department of Psychiatry, University of California, San Francisco). These mice were maintained by backcrossing into a C57BL/6 background for over 30 generations and were housed in a facility at the Institute of Molecular Biology, Academia Sinica. Male Tbr1+/− mice and wild-type littermates at 2–3 months of age were used for the behavioral assay to avoid variations due to the estrus cycle and age. A 12-h light/dark cycle (lights off at 20:00) was maintained in the test room. Food and water were accessed ad libitum. All of the animals were housed in mixed-genotype groups of 3–5 mice per cage and were subjected to experiments randomly without any specific selection criteria. All of the animal experiments were performed with the approval of the Academia Sinica Institutional Animal Care and Utilization Committee.
Many behavioral features of Tbr1+/− mice have been analyzed previously [23, 49]. The results of these studies indicated that Tbr1+/− mice exhibit no obvious defect in locomotion, anxiety, novel object recognition, or contextual fear conditioning. However, mutant mice exhibit impaired amygdala-dependent associative memory, cognitive inflexibility, and reduced sociability. In this report, we focused on olfactory responses to non-social odorants, a feature of ASD. The experiments were conducted as described previously [50,51,52] with some modifications (Fig. 1a). Mice were individually housed during the entire experimental period. After being habituated to the experimental set-up outlined in (1) below, mice were separated into three different groups for the experiments described below in (2), (3), and (4). Data analysis was performed without knowing the genotype of the mice.
(1) Habituation to experimental setup (Fig. 1a, left). Two glass plates with filter papers were placed at the two ends of the home cage for 2 days. During this 2-day habituation, no odorant was added onto the filter papers.
(2) Preference test to investigate whether mice had any preference for specific odorants (Fig. 1a, upper). Limonene (Cat. No. 8.1840, Merck) and 2-heptanol (Cat. No. 8.20619, Merck), two very different odorants, were spotted individually onto filter papers placed at the two ends of the home cage of test mice. The sniffing behaviors of mice towards odorants were recorded using a camera installed on the lid of the cage. We measured the time taken to sniff the filter paper within 5 min of the start of the test. The percentage of sniffing time towards individual odorants over total sniffing time reflected whether mice had a preference for limonene or 2-heptanol (Fig. 1b).
(3) Six consecutive trials to test olfactory sensation (in trial 1), habituation (from trials 2–5), and dishabituation (trial 6) to specific odorants (Fig. 1a, lower). After confirming that mice had no preference for limonene or 2-heptanol, we used these two odorants, together with mineral oil as a control, to conduct the six consecutive trials. In the first five trials (5 min for each trial with 15-min intervals), limonene and mineral oil were individually spotted onto the filter papers placed at the two ends of the home cage of test mice. In the sixth trial, 2-heptanol was spotted onto the glass plate that originally held the filter paper spotted with mineral oil. Mouse behaviors during these six trials were recorded using a camera installed on the lid of the cage. The total time to sniff each filter paper was measured for each trial, which indicated the olfactory response to each odorant. The response to limonene in the first trial represented the “olfactory sensation” of mice. Repetitive exposures to limonene (trials 2 to 5) induced “habituation” and consequently reduced the amount of time mice spent sniffing limonene. The presence of 2-heptanol in trial 6 evoked “dishabituation” and resulted in more time spent sniffing 2-heptanol. Dishabituation induced by the secondary odorant (2-heptanol) indicates “olfactory discrimination”. In addition to assessing time spent sniffing each odorant, we also calculated odor preference indices. For trial 1, the index represented (sniffing time for limonene − sniffing time for mineral oil)/(sniffing time for limonene + sniffing time for mineral oil). For trial 6, the index was equal to (sniffing time for 2-heptanol − sniffing time for limonene)/(sniffing time for 2-heptanol + sniffing time for limonene).
(4) To examine the rescue effect of D-cycloserine, we intraperitoneally injected 20 mg/kg body weight of D-cycloserine into mice 30 min before the first of the six consecutive trials.
Magnetic resonance imaging (MRI)
MRI imaging of mouse brains was performed as described . Briefly, mice were anesthetized and intracardially perfused with 10 ml of 0.1 M PBS containing 10 U/ml heparin (PPC, cat#C504805) and 2 mM ProHance (Gadolinium contrast agent, Bracco Diagnostics, cat#111181) followed by 10 ml of 4% paraformaldehyde/PFA (Cedarlane cat#15710) containing 2 mM ProHance. After perfusion, mice were decapitated. The brain and remaining skull structures were incubated in 4% PFA with 2 mM ProHance overnight at 4 °C, then transferred to 0.1 M PBS containing 2 mM ProHance and 0.02% sodium azide for at least 7 days, before MRI scanning. The anatomical MRI scans used a T2-weighted, three-dimensional fast spin-echo sequence, with a cylindrical acquisition of k-space, and with a TR of 350 ms, TEs of 12 ms per echo for six echoes, a field of view of 20 × 20 × 25 mm3, and matrix size = 504 × 504 × 630 giving an image with 0.040-mm isotropic voxels. Total imaging time was ~ 14 h .
For the volume measurements, we computed the deformations needed to encompass the anatomy of each individual mouse in a common consensus space through iterative linear and nonlinear registrations, the goal being to model how the deformation fields relate to genotype. The Jacobian determinants of the deformation fields were then calculated as measures of volume at each voxel. Volume changes were additionally calculated by warping a pre-existing classified MRI atlas onto the population atlas, which allowed for the volume of 159 segmented structures encompassing cortical lobes, large white matter structures (i.e., corpus callosum), ventricles, cerebellum, brain stem, and olfactory bulbs to be assessed in all brains [55,56,57]. These measurements could then be examined on a voxel-wise basis to localize the differences found within regions or across the brain. Multiple comparisons were accounted for using the false discovery rate (FDR) .
Mice were anesthetized and perfused with PBS, followed by 4% paraformaldehyde (PFA) in PBS. After postfixation with 4% PFA for 3–4 h at 4 °C, immersion in 30% sucrose for 2 days, and cryopreservation at − 80 °C, we collected coronal sections of 50 μm thickness. Brain sections were blocked with the blocking solution from the Tyramide Signal Amplification kit (ThermoFisher Scientific Inc.) for 1 h. Primary antibodies were then added and incubated overnight at 4 °C. The primary antibodies used in this report are as follows: rabbit anti-C-FOS (1:200; Cell Signaling), anti-calretinin (1:250; Swant), anti-calbidin (1:100; Cell Signaling), anti-neurofilament light chain (1:100; AB9568), anti-parvalbumin (1:200; Swant), rat anti-TBR2 (Eomes) (1:200; eBioscience 12-4875, PE-conjugated), anti-TBX21 (T-bet) (1:200; BD Biosciences), anti-VGLUT1 (1:200; Millipore AB5905), anti-VGLUT2 (1:200; Neuromab, 75-067). After washing, secondary antibodies conjugated with streptavidin, Alexa flour-488, -555, or -647 were applied for DAB staining or immunofluorescence staining. Images were acquired with a fluorescence microscope (AxioImager M2; Zeiss) or confocal microscope (LSM700; Carl Zeiss) equipped with a 40 × 1.25 NA objective lens (Plan-Apochromat; Carl Zeiss) and Zen 2009 (Carl Zeiss) acquisition and analysis software. For publication, the images were processed using Photoshop, with minimal adjustment to contrast or brightness applied to the entire images.
Odorant-induced neuronal activation
Adult mice were individually housed for at least 1 week before assay. We added 20 μl of 1 μM limonene in mineral oil or vehicle control (mineral oil alone) to filter paper attached to a glass plate and placed it in the corner of the home cage for 15 min. Mice were anesthetized and perfused with 4% PFA 2 h later. Coronal sections (50 μm thickness) of the olfactory bulb and other brain regions were collected with a cryomicrotome. Immunohistochemistry with anti-C-FOS antibody (1:200; Cell Signaling) followed by DAPI staining was performed as described above. The numbers of C-FOS-positive cells in the regions of the olfactory system (Figs. 6 and 7) were then measured with ImageJ (NIH).
Sections were first attached to gelatin-coated glass slides. After rinsing with water, sections were stained with 0.1% cresyl violet solution (Sigma) in 1% acetic acid for 5 min, followed by rinsing with water, destaining with 70% EtOH, and then dehydration for mounting using Premount.
Data collection and analysis in this report were conducted randomly and blind. All quantitative data are presented as means plus s.e.m. Graphs were plotted using GraphPad Prism 5.0 (GraphPad software). No statistical method was applied to evaluate the sample size, but our sample sizes are similar to those of previous publications [23, 59, 60]. Figure 1c and f, Fig. 6e and f, Fig. 7d and e, and Fig 8a and f were analyzed by unpaired t test. Figure 1d and e and Fig. 8b and c were analyzed by paired t test. Figure 1b was analyzed by two-way repeated measures (RM) ANOVA. p values of less than 0.05 were considered significant. Statistical analysis of MRI data was conducted as described  based on FDR. FDR < 0.1 was considered significant.
Impairment of olfactory discrimination in Tbr1 +/− mice
To investigate whether Tbr1 heterozygosity has any impact on olfaction, we evaluated olfactory sensation and discrimination in Tbr1+/− mice. To set up the assay system, we first tested preferences for two distinct non-social odorants, limonene and 2-heptanol. After 2-day habituation to the presence of filter papers in their home cages, we separately spotted limonene and 2-heptanol onto two filter papers placed at two ends of the home cage (Fig. 1a, upper, preference test). The time spent sniffing limonene and 2-hepatonal was then measured. We found that both wild-type (WT) littermates and Tbr1+/− mice spent similar amounts of time sniffing these two odorants (Fig. 1b; odorant effect: F(1,9) = 2.437, p = 0.153, two-way RM ANOVA), suggesting that both WT and Tbr1+/− mice can sense both limonene and 2-hepatonal and have no preference for either of them.
We then used these two odorants in six consecutive trials to examine the olfactory sensation and discrimination abilities of mice. Limonene and mineral oil (a control) were presented to mice in the first five trials with 15-min intervals (Fig. 1a, lower panel). The time spent sniffing limonene in the first trial indicated the olfactory sensation of mice. WT littermates and Tbr1+/− mice spent comparable amounts of time sniffing limonene in trial 1 (Fig. 1c; t(20) = 1.23, p = 0.2331, unpaired t test). Compared with mineral oil, both Tbr1+/− mice and WT littermates spent significantly longer time sniffing limonene in trial 1 (Fig. 1d, trial 1; WT, t(10) = 6.559, p < 0.0001; Tbr1+/−, t(10) = 5.147, p = 0.0004, paired t test). The results suggested Tbr1+/− mice exhibit normal olfactory sensation. The repetitive exposure to limonene in consecutive trials 2 to 5 habituated mice to limonene and adapted their olfactory responses to this odor (Fig. 1d). We found that time spent sniffing limonene rapidly decreased to levels comparable to those recorded for responses to mineral oil in both Tbr1+/− mice and WT littermates during subsequent trials 2–5 (Fig. 1d; trial 2: WT, t(10) = 1.762, p = 0.1085; Tbr1+/−, t(10) = 0.5437, p = 0.5986, paired t test), indicating that habituation, i.e., olfactory adaptation, is also normal in Tbr1+/− mice.
The olfactory discrimination ability of Tbr1+/− mice was then investigated in trial 6, representing the dishabituation test. Limonene (the familiar odorant) and 2-heptanol (a novel odorant) were simultaneously presented in the home cages of mice during trial 6 (Fig. 1a, lower panel). All WT littermates spent significantly more time sniffing 2-heptanol (Fig. 1e; WT, t(10) = 6.981, p = 0.001, paired t test), suggesting that WT mice were able to distinguish 2-heptanol from limonene. However, of the 11 Tbr1+/− mice we assayed, only five animals spent more time sniffing 2-heptanol (Fig. 1e; Tbr1+/−, t(10) = 2.109, p = 0.0611, paired t test). We then calculated an odor preference index by comparing the limonene and mineral oil data from trial 1 and the 2-heptanol and limonene data from trial 6 (see “Methods” section and Fig. 1f). We found that the preference indices for trial 1 were comparable between WT and Tbr1+/− mice (Fig. 1f; t(20) = 0.4123, p = 0.6845, unpaired t test), further supporting the conclusion that Tbr1+/− mice have no defect in olfactory sensation. However, for trial 6, the preference indices of Tbr1+/− mice were significantly lower than those of WT littermates (Fig. 1f; t(20) = 2.981, p = 0.0074, unpaired t test). These results suggest that deletion of one allele of the Tbr1 gene impairs olfactory discrimination but not olfactory sensation or adaptation.
Tbr1 expression in the olfactory system of mouse brains
To investigate how Tbr1 haploinsufficiency regulates olfaction, we examined Tbr1 expression in the olfactory system of WT mouse brains (Fig. 2a). Consistent with previous findings that TBR1 is expressed in mitral cells, tufted cells, and juxtaglomerular excitatory neurons of the olfactory bulb [26, 32, 61, 62], we also found that TBR1 was mainly expressed in the mitral cell layer and glomerular layer of the olfactory bulb in adult WT mice (Fig. 2b). In addition to the olfactory bulb, immunostaining also detected TBR1 expression in the piriform cortex (PC), mainly at the layer II projection neurons and in the perirhinal cortex (PrC), enriched at layer VI (Fig. 2c). However, there was no TBR1 signal in the olfactory tubercle (OT) (Fig. 2c). These immunostaining results indicate that TBR1 is expressed in several regions of the olfactory system of mouse brains.
Alteration of the olfactory system in Tbr1 +/− mouse brains
We then investigated whether the deletion of an allele of the Tbr1 gene alters anatomic or histological features of the olfactory system in mouse brains. We performed MRI to compare the size of the olfactory system of Tbr1+/− mice and WT littermates. Consistent with previous histological analysis , our MRI results showed that the posterior part of the anterior commissure is the most sensitive region to Tbr1 haploinsufficiency, even without normalization against whole-brain size (Fig. 3a and b). After normalizing against whole-brain size, the anterior part of the anterior commissure and the olfactory bulb (including the glomerular, external plexiform, mitral cell, internal plexiform, and granule cell layers) were smaller in Tbr1+/− mice (Fig. 3a and b). However, the olfactory tubercle, piriform cortex, or perirhinal cortex were not affected by Tbr1 haploinsufficiency (Fig. 3b). We then conducted Nissl staining to investigate whether histological features of the olfactory system were altered by Tbr1 haploinsufficiency. We found that cellular organization and the laminar structure of the olfactory bulb, olfactory tubercle, piriform cortex, and perirhinal cortex were all normal in Tbr1+/− mice (Fig. 3c). Thus, our MRI analysis and Nissl staining suggest that the size, but not structure, of the anterior commissure and olfactory bulb are particularly sensitive to Tbr1 haploinsufficiency.
Characterization of Tbr1 +/− olfactory bulbs using various markers
We performed immunofluorescence staining with various markers to further characterize Tbr1+/− olfactory bulbs. The first set of markers we used comprised members of the TBR1 subfamily of T-box transcription factors, including TBR1, TBR2 (T-brain-2, also known as Eomesodermin or EOMES), and TBX21 (also known as T-bet). Although TBR1 subfamily members are all expressed in mitral cells, tufted cells, and juxtaglomerular excitatory neurons of the olfactory bulb, only some of those cells express all three of these transcription factors . Thus, differential expression of TBR1 subfamily members defines subpopulations of excitatory neurons in olfactory bulbs, though the biological functions of these different subpopulations are still unknown. In Tbr2−/− neurons, TBR1 expression is upregulated, whereas TBX21 protein levels are reduced . We wondered whether Tbr1 haploinsufficiency also influences expression of other members of the TBR1 subfamily. We carried out triple immunostaining using TBR1, TBR2, and TBX21 antibodies to analyze adult olfactory bulbs. Our results revealed that TBR2:TBR1:TBX21 triple-positive mitral cells accounted for a sizeable proportion (~ one third) of all mitral cells in WT mice (Fig. 4, white nuclei in WT). Double-positive cells were also frequently found in WT olfactory bulbs (Fig. 4, yellow or purple nuclei in WT). In Tbr1+/− olfactory bulbs, the general patterns of TBR1 subfamily-positive cells were similar to those of WT mice, but TBR2 seemed to be dominant and the number of triple-positive cells was reduced (Fig. 4, Tbr1+/−). Thus, the properties of projection neurons in olfactory bulbs are likely altered by Tbr1 deficiency.
A previous study indicated that Tbr2 deletion alters expression of vesicular glutamate transporters (VGLUTs) in mitral and tufted cells, and influences dendrodendritic synapses in the external plexiform layer of olfactory bulbs . To investigate whether Tbr1 haploinsufficiency influences the expression of VGLUTs, we performed immunostaining using antibodies against VGLUT1 and VGLUT2. We found that ratios of VGLUT1 and VGLUT2 signals in the glomerular to external plexiform layers were not altered in Tbr1+/− olfactory bulbs compared to those of WT littermates (Fig. 5a and b, Additional file 1: Figure S1). Thus, unlike Tbr2 deficiency , Tbr1 haploinsufficiency does not result in a shift from VGLUT1 to VGLUT2. Based on immunostaining with neurofilament antibody, Tbr2−/− mitral cells exhibit thinner and more disorganized dendrites compared with those of WT cells . In contrast to the outcome of Tbr2 deletion, the dendrites of Tbr1+/− mitral cells became thicker (Fig. 5c, Additional file 1: Figure S1). Thus, TBR1 and TBR2 play differential roles in controlling synapse transmission and dendritic organization of mitral cells.
We then used calretinin, parvalbumin, and calbindin antibodies as markers to monitor interneurons in olfactory bulbs. Calretinin+ neurons were widely distributed at different layers, including the glomerular layer (GL), external plexiform layer (EPL), mitral cell layer (MCL), and granular cell layer (GCL) (Fig. 5d, Additional file 1: Figure S1). All these layers showed fewer calretinin+ neurons in Tbr1+/− olfactory bulbs compared to WT littermates, though only the differences for EPL, MCL, and GCL were significant (Fig. 5g; GL, t(5) = 2.429, p = 0.0595; EPL, t(5) = 11.55, p = < 0.0001; MCL, t(5) = 4.065, p = 0.0097; GCL, t(5) = 2.898, p = 0.0339, unpaired t test). Parvalbumin+ interneurons were enriched at the EPL (Fig. 5e, Additional file 1: Figure S1) and had a lower cell density in Tbr1+/− olfactory bulbs relative to WT littermates (Fig. 5h; t(5) = 4.88, p = 0.0046, unpaired t test). Calbindin+ interneurons were present in the GL (Fig. 5f, Additional file 1: Figure S1) but there was no significant difference between Tbr1+/− mice and WT littermates (Fig. 5i; t(4) = 0.3014, p = 0.7782, unpaired t test). Since TBR1 is not expressed in interneurons, the reduction of calretinin+ and parvalbumin+ interneurons is a non-cell autonomous effect. Only parvalbumin signals were obviously altered in Tbr2−/− mice . Therefore, Tbr1 and Tbr2 exhibit differing non-cell-autonomous effects on interneurons.
Our immunostaining results using various markers suggest that Tbr1 heterozygosity likely influences projection neurons and alters inhibitory interneurons. These defects are specific for Tbr1 haploinsufficiency and cannot be compensated for by the presence of Tbr2.
Reduced neuronal activation in Tbr1 +/− mouse brains
We then investigated whether neuronal activation in the olfactory system is altered by Tbr1 haploinsufficiency, resulting in impairment of olfactory responses. Two hours after exposure to limonene for 15 min, we examined C-FOS expression by immunostaining to monitor neuronal activation (Fig. 6a, b, c, and d). Compared with a mineral oil control, limonene stimulation resulted in more C-FOS-positive cells in the GL of WT mice (Fig. 6e and f; GL, WT, t(10) = 2.863, p = 0.0169, unpaired t test) but not in Tbr1+/− mice (Fig. 6e and f; GL, Tbr1+/−, t(9) = 0.09979, p = 0.9227, unpaired t test). In both the EPL and the MCL, we did not observe any change in C-FOS cell number in WT littermates or Tbr1+/− mice (Fig. 6e and f; EPL: WT, t(10) = 0.911, p = 0.3838; Tbr1+/−, t(9) = 0.6923, p = 0.5062; MCL: WT, t(10) = 1.061, p = 0.3138; Tbr1+/−, t(9) = 0.6838, p = 0.511, unpaired t test). Thus, only the GL exhibits lower neuronal activation upon odor stimulation in Tbr1+/− olfactory bulbs.
In the upper olfactory system of WT mice, the numbers of C-FOS-positive cells in both the anterior piriform and perirhinal cortices, but not olfactory tubercles, was increased upon limonene stimulation compared with a mineral oil control (Fig. 7d and e; WT: anterior piriform, t(12) = 4.486, p = 0.0007; perirhinal, t(12) = 3.17, p = 0.0081; olfactory tubercle, t(12) = 1.172, p = 0.2641, unpaired t test). In Tbr1+/− mice, neither the piriform and perirhinal cortices nor olfactory tubercles exhibited increases of C-FOS-positive cell numbers upon comparing results for limonene with mineral oil control (Fig. 7e; Tbr1+/−: anterior piriform, t(12) = 1.236, p = 0.2401; perirhinal, t(12) = 1.148, p = 0.2734; olfactory tubercles, t(12) = 0.7735, p = 0.4542, unpaired t test). Thus, the defects of neuronal activation in response to odor stimulation primarily lie in the glomerular layer of olfactory bulbs and the piriform and perirhinal cortices of Tbr1+/− mice.
D-cycloserine has a beneficial effect on olfactory discrimination of Tbr1 +/− mice
Our previous study indicated that Tbr1 haploinsufficiency impairs axonal connectivity and neuronal activation of amygdalar neurons . Systemic administration or local infusion of D-cycloserine into amygdalae effectively ameliorates impaired neuronal activation of amygdalae and associated behavioral deficits in social interaction, cognitive flexibility, and memory . Since neuronal activation in the glomerular layer of the olfactory bulb and its piriform and perirhinal cortices was impaired in Tbr1+/− mice upon odor stimulation (Fig. 7), we wondered if the olfactory defects of Tbr1+/− mice could be improved by D-cycloserine treatment. To test this possibility, we intraperitoneally injected D-cycloserine into both WT and Tbr1+/− mice 30 min before undergoing an olfactory discrimination test. Similar to the results without D-cycloserine treatment (Fig. 1), both WT and Tbr1+/− mice behaved comparably in terms of olfactory sensation (Fig. 8a; t(18) = 0.3053, p = 0.7636, unpaired t test) and adaptation to limonene (Fig. 8b). Importantly, in the discrimination test (trial 6), both Tbr1+/− and WT mice spent significantly more time sniffing 2-heptanol, i.e., the novel odorant (Fig. 8c; WT, t(9) = 5.479, p = 0.0004; Tbr1+/−, t(9) = 3.517, p = 0.0065; paired t test). Odor preferences of Tbr1+/− mice in both trials 1 and 6 were also comparable to those of WT mice (Fig. 8d; trial 1, t(18) = 1.601, p = 0.1269; trial 6, t(18) = 1.074, p = 0.2970; unpaired t test). These results suggest that, similar to its effect on amygdalar deficits caused by Tbr1 haploinsufficiency, increased neuronal activation by D-cycloserine ameliorates impaired olfactory discrimination in Tbr1 mutant mice.
Previous reports have shown that Tbr1+/− mice, a mouse model for autism, exhibit reduced social interaction, cognitive inflexibility, and defective associative memory . In this report, we further show that olfactory discrimination to non-social odors is impaired in Tbr1+/− mice. The olfactory bulbs and anterior commissure are smaller in Tbr1+/− mice. Although we observed a reduced population of calretinin+ and parvalbumin+ interneurons in Tbr1+/− olfactory bulbs, neuronal activation in the glomerular layer is still reduced in Tbr1+/− mice upon odorant stimulation, suggesting abnormal local neural circuits in olfactory bulbs of Tbr1+/− mice. In the upper region of the olfactory system, the sizes of piriform and perirhinal cortices are not changed by Tbr1 haploinsufficiency. However, neuronal activation of these two regions is not induced in response to odorant stimulation in Tbr1+/− mice, suggesting that the neuronal circuit from the olfactory bulbs to the upper olfactory system is impaired by Tbr1 haploinsufficiency. Moreover, D-cycloserine treatment to increase neuronal activity rescues the defect of olfactory discrimination in Tbr1+/− mice, echoing a previous study showing that circuit defects in Tbr1 mutant mice lead to lower neuronal activity and abnormal behavior .
Olfactory dysfunction has been reported for patients with ASD [34,35,36,37,38,39, 41, 42]. An alcohol sniff test, a standardized clinical evaluation of olfactory detection, was previously used to show the enhanced olfactory sensitivity of patients with ASD . This test involves using antiseptic swabs of isopropyl alcohol (70% vol.) as stimuli to minimize trigeminal effects and other cognitive demands. It showed that some patients with ASD have a lower threshold for detecting isopropyl alcohol . In other studies using 1-butanol and a variety of food odorants, patients with ASD or Asperger’s syndrome exhibited normal sensing ability but diminished ability to identify different odors, reflecting impaired olfactory discrimination [34, 35, 39]. These studies indicate diverse olfactory phenotypes among patients. However, why and how olfaction is impaired in ASD is unclear. In this report, Tbr1+/− mice exhibit normal olfactory sensation but impaired olfactory discrimination to non-social odors, recapitulating one type of olfactory defect observed in ASD. Importantly, our study revealed defective neural circuits and reduced neuronal activity in the olfactory system caused by Tbr1 deficiency. By increasing neuronal activity through D-cylcoserine treatment, we could improve the olfactory discrimination ability of Tbr1+/− mice. This outcome echoes our previous finding that reduced social interaction, cognitive inflexibility, and impaired associative memory of Tbr1+/− mice are ameliorated by D-cycloserine treatment . Thus, our evidence supports the hypothesis that Tbr1 deficiency alters neural circuits (by changing axonal projection and neuronal activation), resulting in autism-like behaviors, and that these defects can be improved by increasing neuronal activity via D-cycloserine treatment. For ASD patients characterized by NMDAR hypoactivation (such as arises from TBR1 deficiency), D-cycloserine or other compounds with a similar pharmacological effect might represent a potential medicine for ameliorating patient symptoms.
In terms of animal studies, mutations of Fragile X mental retardation 1 (dFmr1) in Drosophila result in lower activity of GABAergic interneurons and thus reduce lateral inhibition of excitatory projection neurons in olfactory glomeruli, resulting in higher activity of projection neurons and consequently impairing odor selectivity . In our current study, we also found that cell numbers of calretinin+ and parvalbumin+ interneurons are reduced in Tbr1+/− olfactory bulbs, particularly in the EPL, MCL, and GCL (Fig. 5). Accordingly, localized inhibition from interneurons is likely to be reduced. It has been shown that mitral cells, the major projection neurons sending output signals to higher brain regions, reciprocally innervate local interneurons in olfactory bulbs . Local interneurons that receive the excitatory signals from mitral cells can increase their activity to inhibit neighboring mitral cells, thereby reducing noise and sharpening the responses of mitral cells, which has been suggested to be a critical process in olfactory discrimination to identify odors and map complex dimensional odors into dynamic ensembles of neuronal activity [64,65,66,67,68]. In addition, the anterior part of the anterior commissure that provides contralateral inhibition between the two olfactory bulbs of the two brain hemispheres is smaller in Tbr1+/− mice (Fig. 3a and b). Thus, olfactory processing within and between two olfactory bulbs is likely defective in Tbr1+/− mice, although detailed electrophysiological recording will be required to further investigate this possibility. Based on our behavioral assays, these defects do not have an impact on olfactory sensation but specifically impair olfactory discrimination, consistent with the idea that local inhibition refines olfactory discrimination .
In olfactory bulbs, Tbr1 haploinsufficiency only alters neuronal activity of the GL in olfactory bulbs. In the upper olfactory system, activation of piriform and perirhinal cortices is also impaired. Together, these findings suggest dysregulation of the neural circuits in the olfactory system, leading to impaired olfactory discrimination. However, it is still unclear why only neuronal activity of the GL in Tbr1+/− olfactory bulbs is reduced. Since mitral cells also form reciprocal connectivity with neurons at the GL and mitral cells in Tbr1+/− olfactory bulbs might not receive precise regulation from local interneurons at the EPL and MCL (see previous paragraph), mitral cells in Tbr1+/− olfactory bulbs might not appropriately activate local neuronal activity at the GL. Consequently, neuronal activation in the GL of Tbr1+/− mice is reduced. Certainly, this explanation is overly simplistic, as olfactory systems exhibit such highly complex local microcircuits with diverse reciprocal connectivity and feed-forward and -backward regulation. More detailed analysis is required to fully understand the circuit defects we observed. Nevertheless, our results echo that since olfaction relies on precise and complex neural circuits, it is extremely sensitive to circuit deficits such as those arising from ASD.
All three members of the TBR1 subfamily, i.e., TBR1, TBR2, and TBR21, are expressed in mitral cells, tufted cells, and juxtaglomerular excitatory neurons . Based on mouse model studies, the functions of these three subfamily members in olfactory bulbs are obviously different from each other. Although TBR1 protein levels are upregulated in Tbr2 conditional knockout mice, expression levels of VGluT1 and VGluT2 are reversed , suggesting that TBR1 upregulation does not compensate for Tbr2 deficiency in VGluT1 and VGluT2 expression. Conversely, although Tbr1 haploinsufficiency results in impaired olfactory discrimination, the ratio of VGLUT1 and VGLUT2 expression in glomerular and external plexiform layers is not obviously altered. It is interesting to note that in the cerebral cortex, TBR1 and TBR2 are expressed sequentially during development of projection neurons. TBR1 is specific for postmitotic neurons , whereas TBR2 is transiently expressed in the subventricular zone directly before TBR1 is expressed . Thus, the functions of TBR1 and TBR2 in the cerebral cortex are also distinct. Since TBR1, TBR2, and TBX21 have highly homologous T-box domains, i.e., the DNA-binding domain located in the central region of the proteins , they likely bind the same DNA sequence. The distinct functions of TBR1, TBR2, and TBX21 are thus more likely to be mediated by the N- and C-terminal regions, which share less similarity in their amino acid sequences . It will be interesting to investigate the molecular functions of the TBR1 subfamily in the future, results of which will further elucidate the regulatory mechanisms of the TBR1 subfamily in neurons. Understanding more about TBR1 and the relationship between TBR1 and other T-Box proteins may provide further information about the molecular etiology of TBR1-related ASD.
Using Tbr1+/− mice, we have demonstrated that TBR1 controls the circuits and activity of the olfactory system in mice. Olfactory discrimination but not olfactory sensation is specifically affected by Tbr1 haploinsufficiency. Importantly, similar to amygdala-dependent behaviors, the olfactory deficiency exhibited by Tbr1+/− mice can be ameliorated by increasing neuronal activity via D-cycloserine treatment. Our study suggests that increased neuronal activity can improve multiple autism-like behaviors in Tbr1+/− mice, confirming that impaired neural circuits and activity are general features caused by Tbr1 deficiency.
Autism spectrum disorders
External plexiform layer
Granule cell layers
Glutamate ionotropic receptor NMDA type subunit
Internal plexiform layer
Mitral cell layer
T-brain-2 or Eomes
T-box-21 or T-bet
Vesicular glutamate transporter 1
Vesicular glutamate transporter 2
Courchesne E, Pierce K, Schumann CM, Redcay E, Buckwalter JA, Kennedy DP, et al. Mapping early brain development in autism. Neuron. 2007;56(2):399–413.
Ziats MN, Edmonson C, Rennert OM. The autistic brain in the context of normal neurodevelopment. Front Neuroanat. 2015;9:115.
Frazier TW, Youngstrom EA, Speer L, Embacher R, Law P, Constantino J, et al. Validation of proposed DSM-5 criteria for autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2012;51(1):28–40.e3.
Mandy WP, Charman T, Skuse DH. Testing the construct validity of proposed criteria for DSM-5 autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2012;51(1):41–50.
Sztainberg Y, Zoghbi HY. Lessons learned from studying syndromic autism spectrum disorders. Nat Neurosci. 2016;19(11):1408–17.
Monteiro P, Feng G. SHANK proteins: roles at the synapse and in autism spectrum disorder. Nat Rev Neurosci. 2017;18(3):147–57.
Lee E, Lee J, Kim E. Excitation/inhibition imbalance in animal models of autism spectrum disorders. Biol Psychiatry. 2017;81(10):838–47.
Schroeder JC, Reim D, Boeckers TM, Schmeisser MJ. Genetic animal models for autism spectrum disorder. Curr Top Behav Neurosci. 2017;30:311–24.
Ito-Ishida A, Ure K, Chen H, Swann JW, Zoghbi HY. Loss of MeCP2 in parvalbumin-and somatostatin-expressing neurons in mice leads to distinct Rett syndrome-like phenotypes. Neuron. 2015;88(4):651–8.
Orefice LL, Zimmerman AL, Chirila AM, Sleboda SJ, Head JP, Ginty DD. Peripheral mechanosensory neuron dysfunction underlies tactile and behavioral deficits in mouse models of ASDs. Cell. 2016;166(2):299–313.
Franco LM, Okray Z, Linneweber GA, Hassan BA, Yaksi E. Reduced lateral inhibition impairs olfactory computations and behaviors in a drosophila model of fragile X syndrome. Curr Biol. 2017;27(8):1111–23.
Zhang D, Yu B, Liu J, Jiang W, Xie T, Zhang R, et al. Altered visual cortical processing in a mouse model of MECP2 duplication syndrome. Sci Rep. 2017;7(1):6468.
Bhattacherjee A, Mu Y, Winter MK, Knapp JR, Eggimann LS, Gunewardena SS, et al. Neuronal cytoskeletal gene dysregulation and mechanical hypersensitivity in a rat model of Rett syndrome. Proc Natl Acad Sci U S A. 2017;114(33):E6952–e61.
Rais M, Binder DK, Razak KA, Ethell IM. Sensory processing phenotypes in fragile X syndrome. ASN neuro. 2018;10. https://doi.org/10.1177/1759091418801092.
Nakai N, Takumi T, Nakai J, Sato M. Common defects of spine dynamics and circuit function in neurodevelopmental disorders: a systematic review of findings from in vivo optical imaging of mouse models. Front Neurosci. 2018;12:412.
Rotschafer SE, Razak KA. Auditory processing in fragile x syndrome. Front Cell Neurosci. 2014;8:19.
Degano AL, Park MJ, Penati J, Li Q, Ronnett GV. MeCP2 is required for activity-dependent refinement of olfactory circuits. Mol Cell Neurosci. 2014;59:63–75.
Lee W, Yun JM, Woods R, Dunaway K, Yasui DH, Lasalle JM, et al. MeCP2 regulates activity-dependent transcriptional responses in olfactory sensory neurons. Hum Mol Genet. 2014;23(23):6366–74.
Daroles L, Gribaudo S, Doulazmi M, Scotto-Lomassese S, Dubacq C, Mandairon N, et al. Fragile X mental retardation protein and dendritic local translation of the alpha subunit of the calcium/calmodulin-dependent kinase II messenger RNA are required for the structural plasticity underlying olfactory learning. Biol Psychiatry. 2016;80(2):149–59.
O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP, et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature. 2012;485:246–50.
O'Roak BJ, Vives L, Fu W, Egertson JD, Stanaway IB, Phelps IG, et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science. 2012;338(6114):1619–22.
De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE, et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature. 2014;515(7526):209–15.
Huang TN, Chuang HC, Chou WH, Chen CY, Wang HF, Chou SJ, et al. Tbr1 haploinsufficiency impairs amygdalar axonal projections and results in cognitive abnormality. Nat Neurosci. 2014;17(2):240–7.
Hevner RF, Shi L, Justice N, Hsueh Y, Sheng M, Smiga S, et al. Tbr1 regulates differentiation of the preplate and layer 6. Neuron. 2001;29(2):353–66.
Remedios R, Huilgol D, Saha B, Hari P, Bhatnagar L, Kowalczyk T, et al. A stream of cells migrating from the caudal telencephalon reveals a link between the amygdala and neocortex. Nat Neurosci. 2007;10(9):1141–50.
Bulfone A, Wang F, Hevner R, Anderson S, Cutforth T, Chen S, et al. An olfactory sensory map develops in the absence of normal projection neurons or GABAergic interneurons. Neuron. 1998;21(6):1273–82.
Chuang HC, Huang TN, Hsueh YP. T-Brain-1 - a potential master regulator in autism Spectrum disorders. Autism Res. 2015;8(4):412–26.
Wang GS, Hong CJ, Yen TY, Huang HY, Ou Y, Huang TN, et al. Transcriptional modification by a CASK-interacting nucleosome assembly protein. Neuron. 2004;42(1):113–28.
Wang TF, Ding CN, Wang GS, Luo SC, Lin YL, Ruan Y, et al. Identification of Tbr-1/CASK complex target genes in neurons. J Neurochem. 2004;91(6):1483–92.
Chuang HC, Huang TN, Hsueh YP. Neuronal excitation upregulates Tbr1, a high-confidence risk gene of autism, mediating Grin2b expression in the adult brain. Front Cell Neurosci. 2014;8:280.
Kristiansen LV, Patel SA, Haroutunian V, Meador-Woodruff JH. Expression of the NR2B-NMDA receptor subunit and its Tbr-1/CINAP regulatory proteins in postmortem brain suggest altered receptor processing in schizophrenia. Synapse. 2010;64(7):495–502.
Mizuguchi R, Naritsuka H, Mori K, Mao CA, Klein WH, Yoshihara Y. Tbr2 deficiency in mitral and tufted cells disrupts excitatory-inhibitory balance of neural circuitry in the mouse olfactory bulb. J Neurosci. 2012;32(26):8831–44.
Mihalas AB, Hevner RF. Control of neuronal development by T-box genes in the brain. Curr Top Dev Biol. 2017;122:279–312.
Suzuki Y, Critchley HD, Rowe A, Howlin P, Murphy DG. Impaired olfactory identification in Asperger's syndrome. J Neuropsychiatry Clin Neurosci. 2003;15(1):105–7.
Bennetto L, Kuschner ES, Hyman SL. Olfaction and taste processing in autism. Biol Psychiatry. 2007;62(9):1015–21.
Galle SA, Courchesne V, Mottron L, Frasnelli J. Olfaction in the autism spectrum. Perception. 2013;42(3):341–55.
Ashwin C, Chapman E, Howells J, Rhydderch D, Walker I, Baron-Cohen S. Enhanced olfactory sensitivity in autism spectrum conditions. Mol Autism. 2014;5:53.
Luisier AC, Petitpierre G, Ferdenzi C, Clerc Berod A, Giboreau A, Rouby C, et al. Odor perception in children with autism spectrum disorder and its relationship to food neophobia. Front Psychol. 2015;6:1830.
Wicker B, Monfardini E, Royet JP. Olfactory processing in adults with autism spectrum disorders. Mol Autism. 2016;7:4.
Thye MD, Bednarz HM, Herringshaw AJ, Sartin EB, Kana RK. The impact of atypical sensory processing on social impairments in autism spectrum disorder. Dev Cogn Neurosci. 2018;29:151–67.
Kumazaki H, Okamoto M, Yoshimura Y, Ikeda T, Hasegawa C, Saito DN, et al. Brief report: odour awareness in young children with autism spectrum disorders. J Autism Dev Disord. 2018. https://doi.org/10.1007/s10803-018-3710-y.
Endevelt-Shapira Y, Perl O, Ravia A, Amir D, Eisen A, Bezalel V, et al. Altered responses to social chemosignals in autism spectrum disorder. Nat Neurosci. 2018;21(1):111–9.
Tsutiya A, Nishihara M, Goshima Y, Ohtani-Kaneko R. Mouse pups lacking collapsin response mediator protein 4 manifest impaired olfactory function and hyperactivity in the olfactory bulb. Eur J Neurosci. 2015;42(6):2335–45.
Bastakis GG, Savvaki M, Stamatakis A, Vidaki M, Karagogeos D. Tag1 deficiency results in olfactory dysfunction through impaired migration of mitral cells. Development. 2015;142(24):4318–28.
Oettl LL, Ravi N, Schneider M, Scheller MF, Schneider P, Mitre M, et al. Oxytocin enhances social recognition by modulating cortical control of early olfactory processing. Neuron. 2016;90(3):609–21.
Peretti S, Mariano M, Mazzocchetti C, Mazza M, Pino MC, Verrotti Di Pianella A, et al. Diet: the keystone of autism spectrum disorder? Nutr Neurosci. 2018;19:1–15.
Boudjarane MA, Grandgeorge M, Marianowski R, Misery L, Lemonnier E. Perception of odors and tastes in autism spectrum disorders: a systematic review of assessments. Autism Res. 2017;10(6):1045–57.
Larsson M, Tirado C, Wiens S. A meta-analysis of odor thresholds and odor identification in autism spectrum disorders. Front Psychol. 2017;8:679.
Lee EJ, Lee H, Huang TN, Chung C, Shin W, Kim K, et al. Trans-synaptic zinc mobilization improves social interaction in two mouse models of autism through NMDAR activation. Nat Commun. 2015;6:7168.
Yang M, Crawley JN. Simple behavioral assessment of mouse olfaction. Curr Protoc Neurosci. 2009;8:24.
Arbuckle EP, Smith GD, Gomez MC, Lugo JN. Testing for odor discrimination and habituation in mice. J Vis Exp. 2015;(99):e52615. https://doi.org/10.3791/52615.
Chang YC, Cole TB, Costa LG. Behavioral phenotyping for autism spectrum disorders in mice. Curr Protoc Toxicol. 2017;72:11.22.1.
Nieman BJ, van Eede MC, Spring S, Dazai J, Henkelman RM, Lerch JP. MRI to assess neurological function. Curr Protoc Mouse Biol. 2018;8(2):e44.
Spencer Noakes TL, Henkelman RM, Nieman BJ. Partitioning k-space for cylindrical three-dimensional rapid acquisition with relaxation enhancement imaging in the mouse brain. NMR Biomed. 2017;30(11). https://doi.org/10.1002/nbm.3802.
Dorr AE, Lerch JP, Spring S, Kabani N, Henkelman RM. High resolution three-dimensional brain atlas using an average magnetic resonance image of 40 adult C57Bl/6J mice. NeuroImage. 2008;42(1):60–9.
Ullmann JF, Watson C, Janke AL, Kurniawan ND, Reutens DC. A segmentation protocol and MRI atlas of the C57BL/6J mouse neocortex. NeuroImage. 2013;78:196–203.
Steadman PE, Ellegood J, Szulc KU, Turnbull DH, Joyner AL, Henkelman RM, et al. Genetic effects on cerebellar structure across mouse models of autism using a magnetic resonance imaging atlas. Autism Res. 2014;7(1):124–37.
Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. NeuroImage. 2002;15(4):870–8.
Sananbenesi F, Fischer A, Wang X, Schrick C, Neve R, Radulovic J, et al. A hippocampal Cdk5 pathway regulates extinction of contextual fear. Nat Neurosci. 2007;10(8):1012–9.
Shih YT, Hsueh YP. VCP and ATL1 regulate endoplasmic reticulum and protein synthesis for dendritic spine formation. Nat Commun. 2016;7:11020.
Faedo A, Ficara F, Ghiani M, Aiuti A, Rubenstein JL, Bulfone A. Developmental expression of the T-box transcription factor T-bet/Tbx21 during mouse embryogenesis. Mech Dev. 2002;116(1–2):157–60.
Kimura N, Nakashima K, Ueno M, Kiyama H, Taga T. A novel mammalian T-box-containing gene, Tbr2, expressed in mouse developing brain. Brain Res Dev Brain Res. 1999;115(2):183–93.
Huang L, Garcia I, Jen HI, Arenkiel BR. Reciprocal connectivity between mitral cells and external plexiform layer interneurons in the mouse olfactory bulb. Front Neural Circuits. 2013;7:32.
Cleland TA, Linster C. Computation in the olfactory system. Chem Senses. 2005;30(9):801–13.
Cleland TA, Sethupathy P. Non-topographical contrast enhancement in the olfactory bulb. BMC Neurosci. 2006;7:7.
Giridhar S, Doiron B, Urban NN. Timescale-dependent shaping of correlation by olfactory bulb lateral inhibition. Proc Natl Acad Sci U S A. 2011;108(14):5843–8.
Dietz SB, Markopoulos F, Murthy VN. Postnatal development of dendrodendritic inhibition in the mammalian olfactory bulb. Front Cell Neurosci. 2011;5:10.
Komarov MSM, Bazhenov M, editors. Olfactory computation in insects. Cham: Springer; 2017.
Englund C, Fink A, Lau C, Pham D, Daza RA, Bulfone A, et al. Pax6, Tbr2, and Tbr1 are expressed sequentially by radial glia, intermediate progenitor cells, and postmitotic neurons in developing neocortex. J Neurosci. 2005;25(1):247–51.
We thank the Animal Facility of the Institute of Molecular Biology, Academia Sinica, for excellent technical assistance, Dr. John O’Brien for English editing, and members of Dr. Yi-Ping Hsueh’s laboratory for relabeling samples for blind experiments.
This work was supported by grants from Academia Sinica (AS-IA-106-L04) and the Ministry of Science and Technology (MOST 106-2321-B-001-019 and 105-2311-B-001-061-MY3) to Y.-P. Hsueh and the Ontario Brain Institute to J.P. Lerch.
Availability of data and materials
Ethics approval and consent to participate
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figure S1. Entire images of olfactory bulbs shown in Fig. 5. Double immunostaining of TBR2 and (A) VGLUT1, (B) VGLUT2, (C) Neurofilament-light chain (NF-LC), (D) Calretinin, (E) Parvalbumin, and (F) Calbindin was performed to compare Tbr1+/− and WT olfactory bulbs. Black and white images in the bottom-left corners of each entire image are DAPI staining results. Scale bars: 200 μm. (PDF 797 kb)
About this article
Cite this article
Huang, TN., Yen, TL., Qiu, L.R. et al. Haploinsufficiency of autism causative gene Tbr1 impairs olfactory discrimination and neuronal activation of the olfactory system in mice. Molecular Autism 10, 5 (2019). https://doi.org/10.1186/s13229-019-0257-5
- Autism spectrum disorders
- Neuronal activation
- Olfactory bulb
- Olfactory discrimination